Page 1 | Search Results | Cancer Discovery | American Association for Cancer Research

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Iron Chelation Therapy Elicits Innate Immune Control of Metastatic Ovarian Cancer

Cancer Discov (2024) 14 (10): 1901–1921.

https://doi.org/10.1158/2159-8290.CD-23-1451

Published: 04 October 2024

View article titled, Iron Chelation Therapy Elicits Innate Immune Control of Metastatic Ovarian Cancer

Includes: Supplementary data

Journal Articles

An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas

Cancer Discov (2023) 13 (1): 216–243.

https://doi.org/10.1158/2159-8290.CD-22-0561

Published: 09 January 2023

View article titled, An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas

Includes: Supplementary data

Journal Articles

SETD2 Haploinsufficiency Enhances Germinal Center–Associated AICDA Somatic Hypermutation to Drive B-cell Lymphomagenesis

Wilfred Leung, Matt Teater, Ceyda Durmaz, Cem Meydan, Alexandra G. Chivu, Amy Chadburn, Edward J. Rice, Ashlesha Muley, Jeannie M. Camarillo, Jaison Arivalagan, Ziyi Li, Christopher R. Flowers, Neil L. Kelleher, Charles G. Danko, Marcin Imielinski, Sandeep S. Dave, Scott A. Armstrong, Christopher E. Mason, Ari M. Melnick

Cancer Discov (2022) 12 (7): 1782–1803.

https://doi.org/10.1158/2159-8290.CD-21-1514

Published: 06 July 2022

View article titled, SETD2 Haploinsufficiency Enhances Germinal Center–Associated AICDA Somatic Hypermutation to Drive B-cell Lymphomagenesis

Includes: Supplementary data

Journal Articles

Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence

Cihangir Duy, Meng Li, Matt Teater, Cem Meydan, Francine E. Garrett-Bakelman, Tak C. Lee, Christopher R. Chin, Ceyda Durmaz, Kimihito C. Kawabata, Eugen Dhimolea, Constantine S. Mitsiades, Hartmut Doehner, Richard J. D'Andrea, Michael W. Becker, Elisabeth M. Paietta, Christopher E. Mason, Martin Carroll, Ari M. Melnick

Cancer Discov (2021) 11 (6): 1542–1561.

https://doi.org/10.1158/2159-8290.CD-20-1375

Published: 01 June 2021

View article titled, Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence

Includes: Supplementary data

Journal Articles

Somatic Mutations Drive Specific, but Reversible, Epigenetic Heterogeneity States in AML

Sheng Li, Xiaowen Chen, Jiahui Wang, Cem Meydan, Jacob L. Glass, Alan H. Shih, Ruud Delwel, Ross L. Levine, Christopher E. Mason, Ari M. Melnick

Cancer Discov (2020) 10 (12): 1934–1949.

https://doi.org/10.1158/2159-8290.CD-19-0897

Published: 01 December 2020

View article titled, Somatic Mutations Drive Specific, but Reversible, Epigenetic Heterogeneity States in AML

Includes: Supplementary data

Journal Articles

Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid Leukemia

Alan H. Shih, Cem Meydan, Kaitlyn Shank, Francine E. Garrett-Bakelman, Patrick S. Ward, Andrew M. Intlekofer, Abbas Nazir, Eytan M. Stein, Kristina Knapp, Jacob Glass, Jeremy Travins, Kim Straley, Camelia Gliser, Christopher E. Mason, Katharine Yen, Craig B. Thompson, Ari Melnick, Ross L. Levine

Cancer Discov (2017) 7 (5): 494–505.

https://doi.org/10.1158/2159-8290.CD-16-1049

Published: 30 April 2017

View article titled, Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid Leukemia

Includes: Supplementary data

Journal Articles

Cell-Cycle Reprogramming for PI3K Inhibition Overrides a Relapse-Specific C481S BTK Mutation Revealed by Longitudinal Functional Genomics in Mantle Cell Lymphoma

David Chiron, Maurizio Di Liberto, Peter Martin, Xiangao Huang, Jeff Sharman, Pedro Blecua, Susan Mathew, Priyanka Vijay, Ken Eng, Siraj Ali, Amy Johnson, Betty Chang, Scott Ely, Olivier Elemento, Christopher E. Mason, John P. Leonard, Selina Chen-Kiang

Cancer Discov (2014) 4 (9): 1022–1035.

https://doi.org/10.1158/2159-8290.CD-14-0098

Published: 01 September 2014

View article titled, Cell-Cycle Reprogramming for PI3K Inhibition Overrides a Relapse-Specific C481S BTK Mutation Revealed by Longitudinal Functional Genomics in Mantle Cell Lymphoma

Includes: Supplementary data

NARROW

Iron Chelation Therapy Elicits Innate Immune Control of Metastatic Ovarian Cancer

An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas

SETD2 Haploinsufficiency Enhances Germinal Center–Associated AICDA Somatic Hypermutation to Drive B-cell Lymphomagenesis

Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence

Somatic Mutations Drive Specific, but Reversible, Epigenetic Heterogeneity States in AML

Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid Leukemia

Cell-Cycle Reprogramming for PI3K Inhibition Overrides a Relapse-Specific C481S BTK Mutation Revealed by Longitudinal Functional Genomics in Mantle Cell Lymphoma

Email alerts

AACR Journals

Iron Chelation Therapy Elicits Innate Immune Control of Metastatic Ovarian Cancer

An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas

SETD2 Haploinsufficiency Enhances Germinal Center–Associated AICDA Somatic Hypermutation to Drive B-cell Lymphomagenesis

Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence

Somatic Mutations Drive Specific, but Reversible, Epigenetic Heterogeneity States in AML

Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid Leukemia

Cell-Cycle Reprogramming for PI3K Inhibition Overrides a Relapse-Specific C481S BTK Mutation Revealed by Longitudinal Functional Genomics in Mantle Cell Lymphoma

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only